Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite—Resolution for Clinical DevelopmentJim Zheng, Jeffrey A. Silverman, Jingyu Zhang et al.|Drug Metabolism and Disposition|2018Cited by 56
Voreloxin, a First-in-Class Anticancer Quinolone Derivative, in Relapsed/Refractory Solid Tumors: A Report on Two Dosing SchedulesRanjana H. Advani, Daniel C. Adelman, David S. Mendelson et al.|Clinical Cancer Research|2010Cited by 45